A new wave of allogeneic CAR-T cell therapies in oncology treatment

Cell & Gene Therapy Insights 2022; 8(4), 549–553

DOI: 10.18609/cgti.2022.082

Published: 20 May 2022
Silvan Tuerkcan, PhD

Silvan Tuerkcan, PhD

JMP Securities, a Citizens Company

“The two big goals of allogeneic CAR-Ts are to get into earlier lines of therapy, and to succeed in solid tumors.”